Pharmaceuticals and Medicines
Please find all related articles below.
Brussels, 16 September 2014 - We are writing to express our astonishment and concern regarding your decision to move the competence for medicinal products and health technologies from the Commissioner in charge of Health to the Commissioner in charge of internal market and industry within the new Commission.
Dear Mr Jean-Claude Juncker, President-elect of the European Commission,
The economic crisis, the ageing of the population, technological advances, and new health threats, including (...)
12 September 2014, Brussels – The public health community has reacted with alarm and disbelief at the ill-thought distribution of responsibilities amongst the in-coming European Commissioners.
In an announcement on Wednesday 10 September, the President-elect (1) revealed that health technology and pharmaceutical policy is being moved from the Health and Food Safety Commissioner to the new Commissioner for Internal Market, Industry, Entrepreneurship and SMEs (2). The European Public (...)
4 July, Brussels – Yesterday the European Court of Justice ruled (1) that access to documents relating to international activity would not be automatically exempt from EU transparency requirements. This decision opens the possibility for the European Commission to make public papers relating to the EU-US trade deal, the Transatlantic Trade and Investment Partnership (TTIP).
EPHA welcomes the ruling and calls for the release of all TTIP documents into the public sphere and for the (...)
Brussels, 1st of July 2014 - The European Parliament election results demonstrate a strong desire for change. From today you, as a new representative of the European people, have the opportunity to turn a new page, make daring political choices and propose institutional changes that will bring the EU closer to its citizens. If you don’t act now, others will take the opportunity to intigate negative reform.
To the Members of the European Parliament
Successive EU treaties have (...)
17 June 2014, Brussels – Today, the Social Platform together with SOLIDAR, the European Federation of Public Services Union (EPSU) and the European Public Health Alliance (EPHA) organised a debate on the ‘possible impacts of the Transatlantic Trade and Investment Partnership (TTIP) on social and health services’ (1). During the discussion, it became clear that the TTIP could have a detrimental impact on essential public services such as social and health services. (...)
From 19 to 24 May 2014, the Sixty-seventh session of the World Health Assembly (WHA) took place in Geneva. The WHA is the supreme decision-making body of World Health Organization (WHO). It determines the policies of the WHO, appoints its Director-General, supervises the organisation’s financial policies, and reviews and approves the proposed programme budget. The WHA is attended by delegations from all WHO Member States and focuses on a specific health agenda prepared by the (...)
The issue of medicine supply shortages has been highlighted by EPHA and its members throughout 2013, and it once again took centre stage at a recent workshop organised by the European Association of Hospital Pharmacists (EAHP). Already in winter, a common position on the issue has been drafted by members of the European Medicine Agency’s Patients’ and Consumers’ / Healthcare Professionals Working Party.
2014 EAHP Congress, Barcelona
The 19th annual EAHP (...)
Access to Medicines
Vaccines and Immunization
Antimicrobial Resistance (AMR)
16 May 2014 - A robust set of hospital pharmacy practice standards for Europe has been agreed at an international Summit in Brussels. These standards should be met across European health systems to ensure safe, effective and optimal use of medicines in collaboration with multi-disciplinary teams. The standards, comprising 44 statements of practice, were agreed at the European Hospital Pharmacy Summit which concluded on Thursday 15th May, and was attended by more than 100 persons.
On 27 March, the European Commission (EC) launched a public consultation on the investor-state dispute settlement (ISDS) chapter within the context of the Transatlantic (ie EU-US) Trade and Investment Partnership (TTIP). Weeks earlier, the EU Trade Commissioner put a halt to negotiations over the ISDS due to mounting criticism from civil society groups and the European Parliament (EP).
07 April 2014 - This consultation has been presented by the EC as a solution to increase transparency (...)
EPHA is organising a joint debate about the pivotal role that patients should play in creating innovative, affordable and quality technologies and products for poverty-related and neglected diseases.
To register, please RSVP with your full name and contact details at email@example.com by March 6th.